CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
DBM +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04533880
NCT04533880N/ACompleted
CompareCT.gov

The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction With Bone-Patellar Tendon Bone Autograft

NYU Langone Health·interventional·Posted Sep 1, 2020·Updated Aug 13, 2024

In Brief

A clinical study evaluating DBM, Calcium phosphate cement, and 1 other intervention for ACL. Completed, enrolled 150 participants across 1 site.

Detailed Summary

One of the common complaints after ACLR with BPTB autograft anterior knee pain. It is thought that this may be due to harvesting the patellar tendon for graft use. Specifically, this may be due to the bone defect that is left after graft harvesting. There is currently no consensus on a gold standard for treating the bone defect with surgeons using multiple commercially available bone void fillers as well as autologous bone graft in standard practice. The purpose of the proposed study is to evaluate the effect bone-void filler on anterior knee pain following ACL reconstruction BPTB autograft.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsACL
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 1, 2020
Enrollment StartAug 31, 2020
Primary CompletionJul 7, 2023
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 5.8 years ago

Interventions

DBMdevice

Demineralized bone matrix (Allosync, CDMB Putty, Arthrex, Naples, FL)

Calcium phosphate cementdevice

Quickset, Arthrex, Naples, FL

Autologous bone graftother

Autologous bone grafting involves utilizing bone obtained from the same individual receiving the graft